Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam Dose and Postoperative Pain in Ambulatory Surgery
NCT03534895Phase 4Unknown
- Sponsor
- University of Porto
- Start
- May 2019
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of midazolam in postoperative pain (3 arms), sponsored by University of Porto. Primary endpoint: Postoperative pain at 24 hours. Status: unknown.
02
Drugs
midazolam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03534895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03534895.